Abbott LaboratoriesABTNYSE
Loading
Cost of Revenue Over TimeStable
Percentile Rank71
3Y CAGR-2.6%
5Y CAGR+2.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-2.6%/yr
vs +9.7%/yr prior
5Y CAGR
+2.7%/yr
Recent deceleration
Acceleration
-12.2pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.72B | -4.4% |
| 2024 | $20.63B | +2.8% |
| 2023 | $20.07B | -5.9% |
| 2022 | $21.33B | +7.4% |
| 2021 | $19.86B | +15.3% |
| 2020 | $17.23B | +13.3% |
| 2019 | $15.21B | +3.1% |
| 2018 | $14.76B | +3.0% |
| 2017 | $14.32B | +49.1% |
| 2016 | $9.61B | - |